Option Care Health, Inc. $OPCH Shares Sold by Riverbridge Partners LLC

Riverbridge Partners LLC lessened its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 12.7% in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 1,262,553 shares of the company’s stock after selling 184,403 shares during the quarter. Riverbridge Partners LLC owned about 0.80% of Option Care Health worth $40,225,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Cornerstone Planning Group LLC increased its stake in shares of Option Care Health by 7,621.4% in the 3rd quarter. Cornerstone Planning Group LLC now owns 1,081 shares of the company’s stock worth $30,000 after acquiring an additional 1,067 shares during the last quarter. Advisory Services Network LLC purchased a new stake in shares of Option Care Health in the third quarter valued at about $35,000. McIlrath & Eck LLC acquired a new stake in Option Care Health during the second quarter worth about $37,000. Caitong International Asset Management Co. Ltd purchased a new position in Option Care Health during the third quarter worth about $38,000. Finally, Hantz Financial Services Inc. boosted its holdings in Option Care Health by 987.7% in the 3rd quarter. Hantz Financial Services Inc. now owns 1,414 shares of the company’s stock valued at $39,000 after purchasing an additional 1,284 shares during the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Trading Down 2.6%

Shares of NASDAQ OPCH opened at $27.75 on Friday. The company has a current ratio of 1.53, a quick ratio of 0.96 and a debt-to-equity ratio of 0.87. The stock has a market capitalization of $4.34 billion, a PE ratio of 21.68, a PEG ratio of 1.60 and a beta of 0.85. Option Care Health, Inc. has a twelve month low of $24.24 and a twelve month high of $36.80. The stock has a fifty day simple moving average of $32.77 and a 200-day simple moving average of $30.72.

Option Care Health (NASDAQ:OPCH) last announced its earnings results on Tuesday, February 24th. The company reported $0.46 EPS for the quarter, meeting analysts’ consensus estimates of $0.46. The company had revenue of $1.47 billion during the quarter, compared to analysts’ expectations of $1.46 billion. Option Care Health had a return on equity of 18.57% and a net margin of 3.67%.Option Care Health’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same period last year, the business posted $0.44 EPS. On average, equities analysts forecast that Option Care Health, Inc. will post 1.22 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. TD Cowen restated a “hold” rating on shares of Option Care Health in a report on Tuesday, January 27th. Deutsche Bank Aktiengesellschaft lifted their target price on Option Care Health from $31.00 to $36.00 and gave the company a “buy” rating in a research report on Tuesday, December 9th. Weiss Ratings reiterated a “hold (c)” rating on shares of Option Care Health in a report on Monday, December 29th. Jefferies Financial Group restated a “buy” rating and issued a $37.00 price objective on shares of Option Care Health in a report on Tuesday, January 13th. Finally, Truist Financial set a $40.00 target price on shares of Option Care Health in a research note on Tuesday, January 13th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, Option Care Health currently has a consensus rating of “Moderate Buy” and a consensus price target of $37.27.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.